Medical technology firm Greatbatch (NYSE: GB – News ) is appropriation Michigan-based implantable medical device pattern firm NeuroNexus Technologies for rounded off $12 million. The treat includes notion of debt and future considerations (undisclosed).
NeuroNexus, founded in 2004, specializes in high-value neural interface technology, components and systems for neuroscience and clinical markets. The entity possesses a immeasurable portfolio of egghead property, core technologies and capabilities to make easy the growth of innovative neural interface gadgets opposite a extended operation of functions inclusive neuromodulation, visual kick and targeted drug smoothness applications.
The merger is approaching to speed up Greatbatch’s foothold opposite cardiovascular and neuromodulation markets. The pooling of NeuroNexus’ technologies and Greatbatch’s capabilities will capacitate the amalgamated entity to supply new world-class investigate products and systems to neuroscientists opposite the globe. Greatbatch expects the merger to be non-dilutive to its practiced working gain in 2012.
 Automated Profits MachineHow to Get Set Up With Your Very Own Ever-Growing, Completely Automated Self Operating Cash-Getting MachineFree Video Report Shows This Amazing New Money-Getting Breakthrough in Action… then Shows You (Step by Step) How to Get It Set Up For Yourself Quickly and Easily Read More: Visit Publisher Site |
Greatbatch is a heading writer and retailer of batteries, capacitors and components used in implantable medical devices. The company’s tip customers add Boston Scientific (NYSE: BSX – News ), Johnson Johnson (NYSE: JNJ – News ), Medtronic (NYSE: MDT – News ) and St. Jude (NYSE: STJ – News ).
Greatbatch has been appropriation interdependent businesses over the final couple of years to speed up sales. The company, in late 2011, paid for Oregon-based battery retailer Micro Power Electronics. The merger is approaching to variegate Greatbatch’s revenues by broadening its foothold in the unstable medical battery marketplace and sensitive growth in other key areas.
Greatbatch continues to deposit in building medical gadgets for its major OEM clients. The company’s tube is strong with a number of products now beneath growth that are approaching to encouragement growth in the long run.
We feel that working results will be upheld by strength at the company’s orthopedic business and vital investments. Greatbatch is approaching to inform its fourth-quarter 2011 results on February 23. We now have an Outperform testimonial on the stock.
Read the Full Research Report on BSX
Read the Full Research Report on MDT
Read the Full Research Report on STJ
Read the Full Research Report on JNJ
Zacks Investment Research
Read the researcher inform on GB,BSX,MDT,STJ,JNJ
|
||||||
|
|
||||||
